- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04392882
Effects of Legumes Consumption on Weight Reduction
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male and female volunteers between the ages of 20 to 70 years
- Body mass index (BMI) of 25 kg/m2 or higher (based on Asia-Pacific guideline)
- Volunteers who have agreed to participate in the study and provided a written content by him/herself
Exclusion Criteria:
- Those with type 2 diabetes, cardiovascular disease, psychiatric problems, thyroid disorders, liver or kidney disease
- Those under the use of any medications (antihypertensive, lipid-lowering, antiplatelet, antidiabetic, etc.).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Legume enriched diet group
|
|
No Intervention: Usual diet group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes of BMI
Time Frame: 12 weeks
|
Changes of weight in kilograms was assessed before and after the intervention. Changes of height in meters was assessed before and after the intervention. Weight and height were combined to report BMI in kg/m^2. |
12 weeks
|
Changes of Insulin Resistance (IR)
Time Frame: 12 weeks
|
Changes of fasting serum glucose in mmol/L was assessed before and after the intervention. Changes of fasting insulin in μIU/mL was assessed before and after the intervention. Fasting insulin and fasting glucose were combined to report IR using the following equation: homeostasis model assessment (HOMA)-IR=[fasting insulin (μIU/mL)×fasting glucose (mmol/L)] /22.5. |
12 weeks
|
Changes of lipid profiles
Time Frame: 12 weeks
|
Triglyceride in mg/dL was assessed before and after the intervention. Total-cholesterol in mg/dL was assessed before and after the intervention. HDL-cholesterol in mg/dL was assessed before and after the intervention. LDL-cholesterol was indirectly estimated using the friedewald formula: LDL-cholesterol= total-cholesterol-[HDL-cholesterol+(triglycerides/5)]. |
12 weeks
|
Changes of serum high C-reactive
Time Frame: 12 weeks
|
Changes of serum high C-reactive in mg/L was assessed before and after the intervention.
|
12 weeks
|
Changes of urinary 8-epi-PGF2α
Time Frame: 12 weeks
|
Changes of urinary 8-epi-PGF2α in pg/mg creatinine was assessed before and after the intervention.
|
12 weeks
|
Changes of adiponectin
Time Frame: 12 weeks
|
Changes of adiponectin in ng/mL was assessed before and after the intervention.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Legumes_Weight Reduction
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obese
-
Zagazig UniversityCompletedAbdominal Surgery | Obese PatientsEgypt
-
University Hospital, GhentCompleted
-
Bristol-Myers SquibbCompletedObese But Otherwise Healthy ParticipantsUnited States
-
University Hospital, Clermont-FerrandUnknownObese Adolescent | Elite Adolescent AthletesFrance
-
Beth Israel Deaconess Medical CenterCompletedObese | Lean | Obese DiabeticsUnited States
-
Sabrin Mohamed Taha AbdelwahabCompletedObese Women With PCOSEgypt
-
University Hospital, Clermont-FerrandUnknown
-
Eisai Inc.CompletedPharmacokinetics in Obese AdolescentsUnited States
-
Glostrup University Hospital, CopenhagenCompletedMorbidly Obese | Intubationtime | IntubationattemptsDenmark
Clinical Trials on Legume enriched diet group
-
Emory UniversityCompleted
-
NHS Greater Glasgow and ClydeUniversity of GlasgowTerminatedDiabetes Mellitus, Type 2 | Renal Insufficiency, ChronicUnited Kingdom
-
Almond Board of CaliforniaKGK Science Inc.CompletedHypercholesterolemia | HDL-CCanada
-
VA Office of Research and DevelopmentUniversity of MarylandCompletedMetabolic SyndromeUnited States
-
University of TorontoMount Sinai Hospital, CanadaCompletedObesity | OverweightCanada
-
University of California, San DiegoAmerican Pistachio GrowersCompleted
-
Institut National de Recherche pour l'Agriculture...National Research Agency, FranceCompleted
-
Institut National de Recherche pour l'Agriculture...CompletedObesity | Insulin ResistanceFrance
-
Queen's University, BelfastUniversity College Dublin; Wageningen University; Dublin City University; Friedrich-Alexander-Universität...RecruitingCognitive Impairment | Cognitive Decline | Poor NutritionUnited Kingdom
-
Tufts UniversityCompleted